PCAT6 and colorectal carcinoma: The data indicate that abnormal PCAT6 overexpression inhibits miR‐204 expression in CRC, thereby promoting HMGA2/PI3K signaling activity, ultimately enhancing CRC chemoresistance to 5‐FU.